VOGLIZOME 0.3

Composition:

• Active Ingredient:

  • Voglibose: 0.3 mg

Formulation:

• Form: Tablet

• Dosage Strength: 0.3 mg of Voglibose per tablet

• Route of Administration: Oral

Status:

• Prescription Status: Prescription-only medication (Rx)

• Regulatory Approval: Approved by drug regulatory authorities (such as the FDA or equivalent) for use in the management of type 2 diabetes mellitus.

Benefits:

• Blood Sugar Control: Voglibose is an alpha-glucosidase inhibitor that works by slowing the breakdown and absorption of carbohydrates in the intestine. This helps to reduce postprandial (after meal) blood sugar spikes.

• Improved Glycemic Control: Particularly effective in controlling post-meal glucose levels, making it a valuable addition to the treatment regimen for patients with type 2 diabetes.

• Complementary Therapy: Can be used in combination with other antidiabetic agents (such as metformin or sulfonylureas) to achieve better overall blood glucose control.

• Reduction in Postprandial Glucose: Helps in reducing the peaks in blood glucose levels that occur after meals, which can be beneficial for overall diabetes management and long-term health.